4.7 Review

The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular Differentiation

Journal

Publisher

MDPI
DOI: 10.3390/ijms17010003

Keywords

apoptosis; B cells; T cells; hnRNP proteins; immune tolerance; pre-mRNA alternative splicing

Funding

  1. Juvenile Diabetes Research Foundation [4-2006-1025]
  2. Diabetes Research Foundation of Western Australia
  3. Ministry of National Education, Republic of Turkey
  4. NATIONAL CANCER INSTITUTE [R03CA180548, R01CA133470] Funding Source: NIH RePORTER
  5. National Center for Complementary & Integrative Health [R21AT008291] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES023720] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Alternative splicing of pre-mRNA helps to enhance the genetic diversity within mammalian cells by increasing the number of protein isoforms that can be generated from one gene product. This provides a great deal of flexibility to the host cell to alter protein function, but when dysregulation in splicing occurs this can have important impact on health and disease. Alternative splicing is widely used in the mammalian immune system to control the development and function of antigen specific lymphocytes. In this review we will examine the splicing of pre-mRNAs yielding key proteins in the immune system that regulate apoptosis, lymphocyte differentiation, activation and homeostasis, and discuss how defects in splicing can contribute to diseases. We will describe how disruption to trans-acting factors, such as heterogeneous nuclear ribonucleoproteins (hnRNPs), can impact on cell survival and differentiation in the immune system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available